Revolution Medicines Inc Sustainability Reports
Revolution Medicines Inc. is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The company focuses on expanding its portfolio of RAS(ON) inhibitors and RAS companion inhibitors to outsmart difficult cancer pathways.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300JU3X0LBCQ65892
FIGI: BBG00829F4Q7
3 reports from 2020 to 2023